I can definitely believe that went on. What is both of their roles with the company Now? I read where Schneider stepped down from his Position! What about Bogart? Plus I get a feeling this company is heading in the right direction. You think it would be hard to accumulate the Staff and team they have with nothing but shady leaders! Plus I think we will all know a lot more within the next year, their inm-750 is going into pre clinacle trials and hopefully by the end of 2018 we might have a better idea where this company is heading! You have to be doing something right to get an article about your company in Forbes! I would like to get lesgetrich's thought on this. Does Bogart and Schneider's past give us anything to really worry about going forward?
Bobin, are you still sceptical about this company for the future? Do you think it's only going to be a penny biotech stock forever or do you think it can do well? The two pipeline drugs they have going into pre clinacle trials 2018 only a fluff to get more investors to buy in or do you believe these have a chance to make it to market? What about patent they filed for there biosynthesis technologies? Is that B'S or is this company just built to rip investors off?
News 
Market Data 
Discover 
AI
